Ticker Symbol: BGMD
BG Medicine Inc
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001407038
Company Profile
bg medicine, inc. (nasdaq:bgmd), the developer of the bgm galectin-3® test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. for additional information about bg medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com.
Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
Standard Industrial Classification Code (SIC code): 0
Address: 124 Washington St Ste 101
Website: http://www.bg-medicine.com/
CEO: Paul Sohmer
Tags:
- Biotechnology
- Health Technology
- Pharmaceuticals: Major
- Professional, Scientific, and Technical Services
- Testing Laboratories
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.00 - $0.00
Beta: -
52wk. High: $0.02
52wk. Low: $0.00
Ytd. Change -66.67%
50 Day Moving Average: -
200 Day Moving Average: $0.00
Shares Outstanding: 11374360
Valuation
Market Cap: $1,137.00
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A